carnitine has been researched along with Addison Disease and Cerebral Sclerosis in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elevated blood C24:0- and C26:0-carnitines and lysophosphatidylcholines (LPCs) were reported as diagnostic biomarkers for X-linked adrenoleukodystrophy (X-ALD)." | 7.96 | Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China. ( Ji, W; Jiang, K; Tian, GL; Wang, YM; Xu, F; Zhuang, YP, 2020) |
| "Elevated blood C24:0- and C26:0-carnitines and lysophosphatidylcholines (LPCs) were reported as diagnostic biomarkers for X-linked adrenoleukodystrophy (X-ALD)." | 3.96 | Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China. ( Ji, W; Jiang, K; Tian, GL; Wang, YM; Xu, F; Zhuang, YP, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, GL | 1 |
| Xu, F | 1 |
| Jiang, K | 1 |
| Wang, YM | 1 |
| Ji, W | 1 |
| Zhuang, YP | 1 |
| Huffnagel, IC | 1 |
| van de Beek, MC | 2 |
| Showers, AL | 1 |
| Orsini, JJ | 1 |
| Klouwer, FCC | 1 |
| Dijkstra, IME | 1 |
| Schielen, PC | 1 |
| van Lenthe, H | 2 |
| Wanders, RJA | 1 |
| Vaz, FM | 2 |
| Morrissey, MA | 1 |
| Engelen, M | 2 |
| Kemp, S | 2 |
| Dijkstra, IM | 1 |
| Ofman, R | 1 |
| Goldhaber-Pasillas, D | 1 |
| Schauer, N | 1 |
| Schackmann, M | 1 |
| Engelen-Lee, JY | 1 |
| Kulik, W | 1 |
| Wanders, RJ | 1 |
| Sandlers, Y | 1 |
| Moser, AB | 2 |
| Hubbard, WC | 1 |
| Kratz, LE | 1 |
| Jones, RO | 1 |
| Raymond, GV | 1 |
| Brown, FR | 1 |
| Van Duyn, MA | 1 |
| Schulman, JD | 1 |
| Rizzo, WB | 1 |
| Snyder, RD | 1 |
| Murphy, JV | 1 |
| Kamoshita, S | 1 |
| Migeon, CJ | 1 |
| Moser, HW | 1 |
5 other studies available for carnitine and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
Topics: Adrenoleukodystrophy; Age Factors; Biomarkers; Carnitine; Case-Control Studies; Child; Dried Blood S | 2020 |
Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Adult; ATP Binding Cassette Transporter, Subfamily D, Member 1; Biomarkers; Ca | 2017 |
C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
Topics: Acetyltransferases; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Me | 2016 |
Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Carnitine; Chromatography, Liquid; Dried Blood Spot Testing; Humans; Infant, N | 2012 |
Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids.
Topics: Adolescent; Adrenoleukodystrophy; Adult; Brain; Carnitine; Clofibrate; Diffuse Cerebral Sclerosis of | 1982 |